Nasopharyngeal cancer (NPC) remains a critical health challenge, particularly in regions such as Southeast Asia where it is more prevalent. Although the disease accounts for a small proportion of all cancers globally, its aggressive nature and the complexity of treatment have spurred rapid developments in the Nasopharyngeal Cancer Treatment Market. This article delves into the Read.